Effect of gonadotropin-releasing hormone agonist and antagonist on steroidogenesis of low responders undergoing in vitro fertilization

References

• Porter R N, Smith W, Craft I L, Abdulwahid N A, Jacobs H S. Induction of ovulation for in-vitro fertilisation using buserelin and gonadotropins. Lancet 1984; ii: 1284–1285
   Google Scholar
• Diedrich K, Diedrich C, Santos E, Zoll C, Al-Hasani S, Reissmann T, Krebs D, Klingmuller D. Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist Cetrorelix during ovarian stimulation. Hum Reprod 1994; 9: 788–791
   PubMed Web of Science ®Google Scholar
• Felberbaum R, Albano C, Ludwig M, Riethmuller-Winzen H, Grigat M, Devroey P, Diedrich K. Ovarian stimulation for assisted reproduction with HMG and concomitant midcycle administration of the GnRH antagonist cetrorelix according to the multiple dose protocol: a prospective uncontrolled phase III study. Hum. Reprod 2000; 15: 1015–1020
   PubMed Web of Science ®Google Scholar
• The European and Middle East Orgalutran Study Group. Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation. Hum Reprod 2001; 16: 644–651
   PubMed Web of Science ®Google Scholar
• Olivennes F, Mannaerts B, Struijs M, Bonduelle M, Devroey P. Perinatal outcome of pregnancy after GnRH antagonist (ganirelix) treatment during ovarian stimulation for conventional IVF or ICSI: a preliminary report. Hum Reprod 2001; 16: 1588–1591
   PubMed Web of Science ®Google Scholar
• Garcia-Velasco J, Isaza V, Vidal C, Landazabal A, Remohi J, Simon C, Pellicer A. Human ovarian steroid secretion in vivo: effects of GnRH agonist versus antagonist (cetrorelix). Hum Reprod 2001; 16: 2533–2539
   PubMed Web of Science ®Google Scholar
• Albano C, Felberbaum R E, Smitz J, Riethmuller-Winzen H, Engel J, Diedrich K, Devroey P. Ovarian stimulation with hMG: results of prospective randomized phase III European study comparing the luteinising hormone-releasing hormone (LHRH) antagonist cetorelix and LHRH-agonist buserelin. Hum Reprod 2000; 15: 526–531
   PubMed Web of Science ®Google Scholar
• Minaretzis D, Alper N, Oskowitz S, Lobel S, Mortola J, Pavlou S. Gonadotropin-releasing hormone antagonist versus agonist administration in women undergoing controlled ovarian hyperstimulation: cycle performance and in vitro steroidogenesis of granulosa-lutein cells. Am J Obstet Gynecol 1995; 172: 1518–1525
   PubMed Web of Science ®Google Scholar
• Akman M, Erden H, Tosun S, Bayazit N, Akosy E, Behceci M. Comparison of agonistic flare up protocol and antagonistic multiple dose protocol in ovarian stimulation of poor responders: results of a prospective randomized trial. Hum Reprod 2001; 16: 868–870
   PubMed Web of Science ®Google Scholar
• Mohamed K, Davies W, Allsopp J, Lashen H. Agonist ‘flare up’ vs antagonist in the management of poor responders undergoing in vitro fertilization (IVF) treatment. Fertil Steril 2005; 83: 331–335
   PubMed Web of Science ®Google Scholar
• Fleming R, Lloyd F, Herbert M, Fenwick J, Griffith T, Murdoch A. Effect of profound suppression of LH during ovarian stimulation on follicular activity, oocyte and embryo function in cycles stimulated with purified FSH. Hum Reprod 1998; 13: 1788–1792
   PubMed Web of Science ®Google Scholar
• Westergaard L G, Laursen S B, Anderson C Y. Increased risk of early pregnancy loss by profound suppression of luteinising hormone during ovarian stimulation in normogonadotrophic women undergoing assisted reproduction. Hum Reprod 2000; 15: 1003–1008
   PubMed Web of Science ®Google Scholar
• Shoham Z, Balen A, Patel A, Jacob H S. Results of ovulation induction using human menopausal gonadotropin or purified follicle-stimulating hormone in hypogonadotropic hypogonadism patients. Fertil Steril 1991; 56: 1048–1053
   PubMed Web of Science ®Google Scholar
• Balasch J, Miro F, Burzaco I, Casamitjana R, Civico S, Ballesca J L, Puerto B, Vanrell J A. The role of luteinising hormone in human follicle development and oocyte fertility: evidence from in-vitro fertilization in a woman with long-standing hypogonadotrophic hypogonadism and using recombinant human FSH. Hum Reprod 1995; 10: 1678–1683
   PubMed Web of Science ®Google Scholar
• Kousta E, White D M, Piazzi A, Loumaye E, Franks S. Successful induction of ovulation and completed pregnancy using recombinant luteinizing hormone and follicle stimulating hormone in a woman with Kallman's syndrome. Hum Reprod 1996; 11: 70–71
   PubMed Web of Science ®Google Scholar
• Fleming R, Rehka P, Deshpande N, Jamieson M E, Yates R WS, Lyall H. Suppression of LH during ovarian stimulation: effects differ in cycles stimulated with purified urinary FSH and recombinant FSH. Hum Reprod 2000; 15: 1440–1445
   PubMed Web of Science ®Google Scholar
• Esposito M A, Barnhart K T, Coutifaris C, Patrizio P. Role of periovulatory luteinizing hormone concentration during assisted reproductive technology cycles stimulated exclusively with recombinant follicle stimulating hormone. Fertil Steril 2001; 75: 519–524
   PubMed Web of Science ®Google Scholar
• Ben-Amor A F, on behalf of the Study Group, Tarlatzis B, Tavmergen E, Shoham Z, Szamatowicz M, Barash A, Amit A, Levitas I, Geva E. The effect of luteinizing hormone administered during late follicular phase in normo-ovulatory women undergoing in vitro fertilization. Hum Reprod 2000; 15: 46
   PubMedGoogle Scholar
• Cedrin-Durnerin I, Grange-Dujardin D, Laffy A, Parneix I, Massin N, Galey J, Theron L, Wolf J P, Conord C, Clement P, et al. Recombinant human LH supplementation during GnRH antagonist administration in IVF/ICSI cycles: a prospective randomized study. Hum Reprod 2004; 19: 1979–1984
   PubMed Web of Science ®Google Scholar
• de Jong D, Macklon N, Eijkemans M, Mannaerts B, Bennink H, Fauser B. Dynamics of the development of multiple follicles during ovarian stimulation for in vitro ferilization using recombinant follicle stimulating hormone (Puregon) and various doses of the gonadotropin-releasing hormone antagonist ganirelix (Orgalutran/Antagon). Fertil Steril 2001; 75: 688–693
   PubMed Web of Science ®Google Scholar
• Hillier S G, Whitelaw P F, Smyth C D. Follicular oestrogen synthesis: the ‘two-cell two-gonadotropin’ model revisited. Mol Cell Endocrinol 1994; 100: 51–54
   PubMed Web of Science ®Google Scholar
• Latouche J, Crumeyrolle-Arias M, Jordan D, Kopp N, Augendre-Ferrante B, Cedard L, Haour F. GnRH receptors in human granulosa cells: anatomical localization and characterization by autoradiographic study. Endocrinology 1998; 125: 1739–1741
   Google Scholar
• Minaretzis D, Jakubowski M, Mortola J, Pavlou S. Gonadotropin-releasing hormone receptor gene expression in human ovary and granulosa lutein cells. J Clin Endocrinol Metab 1995; 80: 430–434
   PubMed Web of Science ®Google Scholar
• Hsueh A J, Erickson G F. Extrapituitary action of gonadotropin-releasing hormone: direct inhibition ovarian steroidogenesis. Science 1979; 204: 854–855
   PubMed Web of Science ®Google Scholar
• Pellicer A, Miro F. Steroidogenesis in vitro of human granulose-luteal cells pretreated in vivo with gonadotropin-releasing hormone analogs. Fertil Steril 1990; 54: 590–596
   PubMedGoogle Scholar
• Bussenot I, Azoulay-Barjonet C, Parinaud J. Modulation of the steroidogenesis of cultured human granulosa-lutein cells by gonadotropin-releasing hormone analogs. J Clin Endocrinol Metab 1993; 76: 1376–1379
   Google Scholar
• Valbuena D, Pellicer A, Guanes P P, Remohi J, Simon C. Effect of disruption versus continuation of gonadotrophin-releasing agonist after human chorionic gonadotrophin administration on corpus luteum function in patients undergoing ovulation induction for in-vitro fertilization. Hum Reprod 1997; 12: 2118–2122
   Google Scholar
• The European Orgalutran Study Group, Borm G, Mannaerts B. Treatment with the gonadotrophin-releasing hormone antagonist ganirilex in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial. Hum Reprod 2000; 15: 1490–1498
   Google Scholar